Close Menu

NIAID

The funds will go to study technologies for use in diagnosing, preventing, and treating tuberculosis, malaria, and other neglected diseases.

The $7.3 million in grants will support development of rapid lab and hospital tests.

Recovery Act funds will grant $20 million to worthy RCE projects, a five-year plan may total $455 million, and a new center is planned.

The three centers are at the Broad Institute and the J. Craig Venter Institute, which each won a $43 million contract, and the University of Maryland School of Medicine's Institute for Genome Sciences, which received $20 million.

Short Reads

Premium

News in brief

The first in a series of programs will support studies of HIV-1 persistence, including host and pathogen genetics.

Nearly $14 million next year will support centers to study malaria and develop gene-based diagnostics.

Short Reads

Premium

Genome Analysis Centre, University of Barcelona, NIAID, Massachusetts Institute of Technology, J. Craig Venter Institute, University of Maryland, SeqWright, Hologic, BioReference Laboratories, GeneDx, University of Michigan, Genomatix Software, NHGRI

JCVI, MIT, and the University of Maryland, Baltimore, will use the funds to conduct genome sequencing projects.

Pages

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.